Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on Prometheus Biosciences, Raises Price Target to $47

SVB Leerink analyst Thomas Smith maintains Prometheus Biosciences (NASDAQ:RXDX) with a Outperform and raises the price target from $43 to $47.
byBenzinga Newsdesk
December 8, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Thomas Smith maintains Prometheus Biosciences (NASDAQ:RXDX) with a Outperform and raises the price target from $43 to $47.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0